Current State of MRSA Infections and Practical Chemotherapy with Arbekacin. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin.
1) KONDO, S.; K. IINUMA, H. YAMAMOTO, K. MAEDA & H. UMEZAWA: Syntheses of1-N-{(S)-4-amino-2-hydroxybutyryl}-kanamycin B and-3', 4'-didedoxykanamycin B active against kanamycin-resistant bacteria. J. Antibiotics 26: 412-415, 1973
4) AOKI, Y. & H.KASHIWAGI: Changing profiles of antibiotic susceptibility of methicillin-resistant Staphylococcus aureus (MRSA). Chemotherapy 39: 570-576, 1991
5) SANDE, M. & G. MANDELL: Antimicrobial agents-vancomycin. In GOODMAN and GILMAN'S the Pharmacological Basis of Therapeutics. Sixth edition. Ed. by GILMAN, A. G.; L. S. GOODMAN & A. GILMAN, p.1231, Macmillan publishing Co., Inc., 1980 (New York)